OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells
Liesel Goveas, Eugénie Mutez, Marie‐Christine Chartier‐Harlin, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 981-981
Open Access | Times Cited: 8
Liesel Goveas, Eugénie Mutez, Marie‐Christine Chartier‐Harlin, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 981-981
Open Access | Times Cited: 8
Showing 8 citing articles:
Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson’s Disease
Mohammad Dehestani, Hui Liu, Thomas Gasser
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1030-1030
Open Access | Times Cited: 25
Mohammad Dehestani, Hui Liu, Thomas Gasser
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1030-1030
Open Access | Times Cited: 25
Role of Dardarin and Isthmin-1 in the Protective Effect of Hydroxytyrosol Against Corn Syrup-Induced Liver Damage
Elif Onat, Nevin Kocaman, Serhat Hançer, et al.
Cureus (2025)
Open Access
Elif Onat, Nevin Kocaman, Serhat Hançer, et al.
Cureus (2025)
Open Access
PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation
Lucia Iannotta, Marco Emanuele, Giulia Favetta, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Lucia Iannotta, Marco Emanuele, Giulia Favetta, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Precision medicine for Parkinson’s disease: The subtyping challenge
Mark Frasier, Brian Fiske, Todd Sherer
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 8
Mark Frasier, Brian Fiske, Todd Sherer
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 8
Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date
Margaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 773-788
Closed Access | Times Cited: 1
Margaux Morez, Antonio Jesús Lara Ordóñez, Patricia Melnyk, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 773-788
Closed Access | Times Cited: 1
A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
Antoine Marchand, Alessia Sarchione, Panagiotis S. Athanasopoulos, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1018-1018
Open Access | Times Cited: 5
Antoine Marchand, Alessia Sarchione, Panagiotis S. Athanasopoulos, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1018-1018
Open Access | Times Cited: 5
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson′s Disease
Ilda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1761-1767
Open Access | Times Cited: 5
Ilda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.
Movement Disorders (2022) Vol. 37, Iss. 8, pp. 1761-1767
Open Access | Times Cited: 5
Functional analyses of two novel LRRK2 pathogenic variants in familial Parkinson’s disease
Ilda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Ilda Coku, Eugénie Mutez, Sabiha Eddarkaoui, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
